Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Arcturus Therapeutics Holdings (ARCT) Accumulated Depreciation & Amortization (2018 - 2025)

Arcturus Therapeutics Holdings' Accumulated Depreciation & Amortization history spans 8 years, with the latest figure at $12.5 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 5.76% year-over-year to $12.5 million; the TTM value through Dec 2025 reached $12.5 million, up 5.76%, while the annual FY2025 figure was $12.5 million, 5.76% up from the prior year.
  • Accumulated Depreciation & Amortization reached $12.5 million in Q4 2025 per ARCT's latest filing, up from $12.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $13.4 million in Q2 2025 to a low of $3.4 million in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $7.9 million, with a median of $7.5 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 51.47% in 2023, then increased 5.76% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $4.3 million in 2021, then skyrocketed by 35.88% to $5.8 million in 2022, then skyrocketed by 51.13% to $8.7 million in 2023, then surged by 35.14% to $11.8 million in 2024, then rose by 5.76% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Accumulated Depreciation & Amortization are $12.5 million (Q4 2025), $12.0 million (Q3 2025), and $13.4 million (Q2 2025).